Perrigo Co. PLC | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
441,900.00
205,300.00
42,500.00
4,012,800.00
119,600.00
131,000
Depreciation, Depletion & Amortization
160,200.00
358,900.00
182,400.00
457,000.00
444,800.00
423,600
Other Funds
15,600.00
135,000.00
8,400.00
9,300.00
113,800.00
75,700
Funds from Operations
625,600.00
758,300.00
321,700.00
756,400.00
802,800.00
612,400
Changes in Working Capital
71,800.00
64,800.00
120,800.00
101,500.00
103,900.00
19,400
Net Operating Cash Flow
553,800.00
693,500.00
200,900.00
654,900.00
698,900.00
593,000
Capital Expenditures
104,100.00
171,600.00
77,800.00
171,300.00
88,600.00
Sale of Fixed Assets & Businesses
-
6,200.00
-
69,100.00
154,600.00
Purchase/Sale of Investments
8,600.00
66,400.00
-
4,500.00
2,200,000.00
Net Investing Cash Flow
947,800.00
1,704,800.00
708,100.00
175,000.00
2,338,100.00
Cash Dividends Paid - Total
33,000.00
46,100.00
36,300.00
83,200.00
91,100.00
Issuance/Reduction of Debt, Net
596,300.00
1,206,800.00
689,400.00
174,200.00
2,609,000.00
Net Financing Cash Flow
577,200.00
1,028,000.00
149,600.00
268,700.00
3,004,700.00
Net Change in Cash
177,400.00
19,600.00
367,800.00
204,500.00
56,400.00
Free Cash Flow
449,700.00
521,900.00
123,100.00
548,700.00
610,300.00
Deferred Taxes & Investment Tax Credit
5,700.00
53,800.00
120,000.00
990,900.00
48,900.00
17,900
Net Assets from Acquisitions
852,300.00
1,605,800.00
791,600.00
427,400.00
400.00
Other Sources
-
-
166,300.00
353,700.00
87,300.00
Change in Capital Stock
1,700.00
2,300.00
495,100.00
2,000.00
190,800.00
Exchange Rate Effect
5,800.00
2,900.00
10,200.00
6,700.00
24,100.00
Other Uses
-
-
5,000.00
3,600.00
14,800.00

About Perrigo Co.

View Profile
Address
The Sharp Building
Dublin Dublin 2
Ireland
Employees -
Website http://www.perrigo.com
Updated 07/08/2019
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.